Company intelligence / Profile preview

bioMérieux

Marcy-l'Étoile, Auvergne-Rhône-Alpes, Francebiomerieux.com ↗
Ownership
Public · BIM
Employees
~13000
Development stage
Other
01

Overview

bioMérieux’s diagnostic products are widely adopted globally in clinical microbiology labs and hospitals. Their systems are validated by regulatory agencies including FDA clearance for several platforms. The company continues to launch new products addressing rapid pathogen detection and antimicrobial resistance with strong commercial performance worldwide.

Therapeutic areas
OtherOncologyCardiovascularInfectious Diseases
Modalities
DeviceDiagnostic reagentSoftware
Industry
Molecular Diagnostics
02

Partnerships

Quanterix – development of ultrasensitive multiplex immunoassaysOxford Nanopore – investment partnership on nanopore-based molecular sensing technologyDay Zero Diagnostics – acquisition agreement for genome sequencing/machine learning infectious disease diagnostics assets
03

Financials

Market cap
$12.2B
Total revenue
$4.5B
Enterprise value
$11.9B

Beyond the preview

Go deeper on bioMérieux.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bioMérieux.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call